维普中文期刊产品整合服务
75篇 您的检索式:作者名="KIMBALL AB"
    题名 作者 年代 出处 被引量
1Clinical and immunologic assessment of patients with psoriasis in a randomized, dnuble-blind, placebo-controlled trial using recombinant human interleukin 10显示文摘Kimball AB Kawamura T Tejura K 2002Arch Dermatol2002,138,10:1
2The psychosocial bur- den of psoriasis显示文摘Kimball AB Jacobson C Weiss S 2005Am J Clin Dermatol2005,6,6:1
3Efficacy and safety of ustekinumab,a human interleukin-12/23 monoclonal antibody,in patients with psoriasis:76-week result from randomized,double-blind,Placebo-controlled trial显示文摘Leonardi CL Kimball AB Papp KA 2008Lancet2008,371,9625:1
4Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in pa- tients with psoriasis: 76-week results fi'om a randomised, dou- ble-blind, placebo-controlled trial (PHOENIX 1)显示文摘Leonardi CL Kimball AB Papp KA 2008Lancet2008,371,9625:1
5Psoriasis Area Severity Index and the Dermatology Life Quality Index: the correlation between disease severity and psychological burden in patients treated with biological therapies 显示文摘Mattei PL Corey KC Kimball AB 2014J Eur Acad Dermatol Venereol2014,28,3:1
6Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial显示文摘Kimball AB Kaczvinsky JR Li J 2010Br J Dermatol2010,162,2:1
7Reduction in the appear- ance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N - acetyl glucosamine : re- suits of a randomized, double - blind, vehicle - controlled trial 显示文摘Kimball AB Kaczvinsky JR Li J 2010Br J Dermatol2010,162,2:1
8Advances in the treatment of acne显示文摘Kimball AB 2008J Repr- od Med2008,53,9:1
9Safey and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal anti- body,in the treatment of moderate to severe chronic plaque pso- riasis:results of a randomized, placebo-controlled,phase 2 trial显示文摘Kimball AB Gordon KB Langley RG 2008Arch Dermatol2008,144,2:1
10Efficacy and safety of ustekinumab,a human interleukin-12/23 mono- clonal antibody,in patients with psoriasis: 76-week resuhs from a randomised, doubleblind, placebo-controlled trial (PHOENIX 1 ) 显示文摘Leonardi CL Kimball AB Papp KA 2008Lancet2008,371,9625:1
11Acne and oral contraceptives:update on women's health screening guidelines显示文摘Frangos JE Alavian CN Kimball AB 0,,05:1
12Coro-nary heart disease and stroke risk in patients with psoriasis :retrospective analysis 显示文摘Kimball AB Guerin A Latremouille-Viau D 2010Am J Med2010,123,4:1
13The psycho- social burden of psoriasis显示文摘KIMBALL AB JACOBSON C WEISS S 2005Am J Clin Dermatol2005,6,6:1
14Psoriasis Area Severity Index (PA- SI) and the Dermatology Life Quality Index (DLQI) :the correlation be- tween disease severity and psychological burden in patients treated with biological therapies 显示文摘Mattei PL Corey KC Kimball AB 2014J Eur Aead Dermatol Venereol2014,28,3:1
15Quality of life and treatment satis-faction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only:resuhs of the 2005 Spring US National Psoriasis Foundation Survey 显示文摘Ciocon DH Horn E J Kimball AB 2008Am Clin Dermatol2008,9,2:1
16The psychosocial burden of psoriasis 显示文摘Kimball AB Jacobson C 2005Am J Clin Dermatol2005,6,6:1
17The psychosocial burden of psoriasis显示文摘Kimball AB Jacobson C Weiss S 2005AmJ Clin Dermato12005,6,6:1
18Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis:76-week results from s randomized, double-blind, placebo-controlled trial (PHOENIX1) 显示文摘Leonardi CL Kimball AB Papp KA 2008Lancet2008,371,9625:1
19OBSERVE-5 interim a-nalysis:An observational postmarketing safety registry of etanercept for the treatment of psoriasis显示文摘Kimball AB Pariser D Yamauchi PS 2013J Am Acad Dermatol2013,,:1
20Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy:results from the educate trial显示文摘Kimball AB Jackson JM Sobell JM 2007J Drugs Dermatol2007,6,3:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费